Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

SR Space has started collecting applications for Pre-IPO participation

7/19/24 OTCI

Lenenergo purchases charging stations

7/19/24 LSNG

Rostelecom consolidated 100% of BFT-Holding

7/19/24 RTKM

Rosdorbank's additional issue is placed at the lower limit

7/18/24 RDRB

Cherkizovo reports for 6 months of 2024 by RAS

7/18/24 GCHE

Nornickel is negotiating the construction of a nickel plant in China

7/18/24 GMKN

X5 Retail Group launched parcel delivery

7/18/24 X5

VSMPO-AVISMA reported for 6 months of 2024 by RAS

7/18/24 VSMO

Zaimer increased the volume of loans to new clients by 30.9%

7/18/24 ZAYM

Transneft reported for 6 months of 2024 by RAS

7/18/24 TRNFP